{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:11:33Z","timestamp":1760055093699,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.medmal.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T09:00:29Z","timestamp":1373274029000},"page":"309-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ten years of experience with the pneumococcal conjugate 7-valent vaccine in children"],"prefix":"10.1016","volume":"43","author":[{"given":"C.","family":"Weil Olivier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2013.04.006_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijantimicag.2008.01.021","article-title":"Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species","volume":"32","author":"Pletz","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2013.04.006_bib0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.inf.0000215004.85582.30","article-title":"Invasive pneumococcal disease burden in Hong Kong children","volume":"25","author":"Ho","year":"2006","journal-title":"Ped Inf Dis J"},{"key":"10.1016\/j.medmal.2013.04.006_bib0015","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0020","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.vaccine.2009.05.037","article-title":"Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France","volume":"28","author":"Cohen","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-3099","article-title":"Continued impact of pneumococcal conjugate vaccine on carriage in young children","volume":"124","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2013.04.006_bib0030","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.medmal.2013.04.006_bib0035","unstructured":"Varon E., C. Janoir, L. Gutmann. CNRP\u2013Rapport d\u2019activit\u00e9 2009\u00a0: Epid\u00e9miologie 2008. Accessed at http:\/\/www.invs.sante.fr\/surveillance\/cnr\/rapport_cnrp_2009.pdf."},{"key":"10.1016\/j.medmal.2013.04.006_bib0040","unstructured":"Dorl\u00e9ans F, Varon E, Lepoutre A, Georges S, Gutmann L, L\u00e9vy-Bruhl D et les microbiologistes du r\u00e9seau Epibac et du r\u00e9seau des Observatoires r\u00e9gionaux du pneumocoque. Impact de la vaccination par le vaccin antipneumococcique conjugu\u00e9 heptavalent sur l\u2019incidence des infections invasives \u00e0 pneumocoques en France. Analyse des donn\u00e9es de 2008. http:\/\/www.invs.sante.fr\/recherche\/index2.asp?txtQuery=pneumocoque&Submit.x=8&Submit.y=6."},{"key":"10.1016\/j.medmal.2013.04.006_bib0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Active Bacterial Core Surveillance\/Emerging Infections Program Network sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0050","first-page":"253","article-title":"Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine \u2013\u00a0United States, 2007","volume":"59","author":"Centers for Disease Control Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.medmal.2013.04.006_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/599827","article-title":"Changing epidemiology of invasive pneumococcal disease in Canada, 1998\u20132007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study","volume":"49","author":"Kellner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0060","unstructured":"Institut national de sant\u00e9 publique du Qu\u00e9bec. Programme de surveillance du pneumocoque\u00a0: rapport 2008 http:\/\/www.inspq.qc.ca\/pdf\/publications\/1038_SurvPneumocoque2008.pdf."},{"key":"10.1016\/j.medmal.2013.04.006_bib0065","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/652440","article-title":"The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes","volume":"50","author":"Lehmann","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0070","doi-asserted-by":"crossref","unstructured":"De Carvalho H, Muscat M, Monnet D L, Giesecke J, Lopalco P L. Use of seven - valent pneumococcal conjugate vaccine (PCV 7) in Europe, 2001-2007 Eurosurveillance 2009; 14:N\u00b012 http:\/\/www.eurosurveillance.org\/images\/dynamic\/EE\/V14N12\/art19159.pdf.","DOI":"10.2807\/ese.14.12.19159-en"},{"key":"10.1016\/j.medmal.2013.04.006_bib0075","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.vaccine.2008.03.087","article-title":"Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway","volume":"26","author":"Vestrheim","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0080","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2010.01.017","article-title":"Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme","volume":"28","author":"Harboe","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0085","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","article-title":"Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands","volume":"16","author":"Rodenburg","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0090","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/j.vaccine.2009.04.057","article-title":"Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany","volume":"27","author":"R\u00fcckinger","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0095","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/516779","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study","volume":"44","author":"Barricarte","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10096-008-0693-1","article-title":"Invasive Streptococcus pneumoniae infections in children and older adults in the North of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine","volume":"28","author":"P\u00e9rez-Trallero","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0105","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JCM.44.4.1224-1228.2006","article-title":"Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland","volume":"44","author":"Clarke","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2013.04.006_bib0110","unstructured":"hpa. Cumulative weekly number of reports of Invasive Pneumococcal Disease due to any of the seven serotypes in Prevenar 7\u2122 http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/Pneumococcal\/EpidemiologicalDataPneumococcal\/CurrentEpidemiologyPneumococcal\/InPrevenar7."},{"key":"10.1016\/j.medmal.2013.04.006_bib0115","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis","volume":"123","author":"Pavia","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2013.04.006_bib0120","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1469-0691.2009.02904.x","article-title":"Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain","volume":"15","author":"Guevara","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2013.04.006_bib0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eimc.2008.03.001","article-title":"Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)","volume":"27","author":"Artiles","year":"2009","journal-title":"Enferm Infec Microbiol Clin"},{"key":"10.1016\/j.medmal.2013.04.006_bib0130","series-title":"Sources de donn\u00e9es et donn\u00e9es actuelles.","article-title":"Mesure de la couverture vaccinale en France","author":"Guthmann","year":"2012"},{"key":"10.1016\/j.medmal.2013.04.006_bib0135","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2013.04.006_bib0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2013.04.006_bib0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1542\/peds.2009-3109","article-title":"National hospitalization trends for pediatric p neumonia and associated complications","volume":"126","author":"Lee","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2013.04.006_bib0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1542\/peds.2009-0184","article-title":"Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine","volume":"125","author":"Li","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2013.04.006_bib0155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/INF.0b013e31817cf76f","article-title":"Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada","volume":"27","author":"De Wals","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2013.04.006_bib0160","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.vaccine.2009.01.052","article-title":"Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy","volume":"27","author":"Durando","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0165","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/thx.2010.137802","article-title":"Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997\u20132008","volume":"65","author":"Koshy","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.medmal.2013.04.006_bib0170","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.vaccine.2009.04.021","article-title":"Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines","volume":"27","author":"Rodgers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0175","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2013.04.006_bib0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1542\/peds.2007-0619","article-title":"Trends in acute otitis media-related","volume":"121","author":"Zhou","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2013.04.006_bib0185","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0b013e3181c1bc48","article-title":"New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine","volume":"29","author":"Casey","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2013.04.006_bib0190","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2013.04.006_bib0195","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2009.12.054","article-title":"Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule","volume":"28","author":"Vestrheim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0200","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/01.inf.0000143645.58215.f0","article-title":"Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates","volume":"23","author":"Pelton","year":"2004","journal-title":"Pediatr Inf Dis J"},{"key":"10.1016\/j.medmal.2013.04.006_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000084","article-title":"Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002\u20132007","author":"Sabuncu","year":"2009","journal-title":"Plos Medecine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3181c15471","article-title":"Massachusetts department of public health changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007","volume":"29","author":"Hsu","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.medmal.2013.04.006_bib0215","doi-asserted-by":"crossref","first-page":"C22","DOI":"10.1016\/j.vaccine.2009.06.004","article-title":"Serotype replacement in perspective","volume":"27","author":"Dagan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.04.006_bib0220","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0225","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0230","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2009-2150","article-title":"Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use","volume":"126","author":"Pilishvili","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2013.04.006_bib0235","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jpeds.2009.10.008","article-title":"Active Bacterial Core surveillance team Invasive pneumococcal infections among vaccinated children in the United States","volume":"156","author":"Park","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.medmal.2013.04.006_bib0240","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pediatric pneumococcal serotypes in 4 European countries","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.medmal.2013.04.006_bib0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10096-007-0417-y","article-title":"Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation","volume":"27","author":"Bingen","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"21","key":"10.1016\/j.medmal.2013.04.006_bib0250","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.vaccine.2010.03.030","article-title":"A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination","volume":"28","author":"Van Effelterre","year":"2010","journal-title":"Vaccine"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X13001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X13001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:12:28Z","timestamp":1759972348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X13001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0399077X13001364"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2013.04.006","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten years of experience with the pneumococcal conjugate 7-valent vaccine in children","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}